Beyond the AJR: Prostate Cancer Screening-Safe Omission of Biopsy in Patients With Negative MRI and the Need for High-Quality Imaging Standards
- PMID: 39660828
- DOI: 10.2214/AJR.24.32431
Beyond the AJR: Prostate Cancer Screening-Safe Omission of Biopsy in Patients With Negative MRI and the Need for High-Quality Imaging Standards
Comment on
-
Results after Four Years of Screening for Prostate Cancer with PSA and MRI.N Engl J Med. 2024 Sep 26;391(12):1083-1095. doi: 10.1056/NEJMoa2406050. N Engl J Med. 2024. PMID: 39321360 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources